Literature DB >> 20659270

Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): a patient-reported outcome (PRO) measure.

Nancy Kline Leidy1, Teresa K Wilcox, Paul W Jones, Lindsey Murray, Randall Winnette, Kellee Howard, Jennifer Petrillo, John Powers, Sanjay Sethi.   

Abstract

BACKGROUND: This article describes the qualitative methods used to develop the EXAcerbation of Chronic Pulmonary Disease Tool (EXACT), a new patient-reported outcome (PRO) instrument for evaluating frequency, severity, and duration of exacerbations of chronic obstructive pulmonary disease (COPD).
METHODS: Focus groups and interviews were conducted in the United States with COPD patients treated for exacerbations during the past 6 months. Participants were asked to describe exacerbation attributes, care-seeking cues, and indications of progression and recovery. An iterative process was used to identify themes in the data to inform instrument content and structure. Cognitive debriefing interviews were performed to evaluate and revise the draft item pool. Experts in COPD, instrument development, and clinical research participated in the process.
RESULTS: Eighty-three subjects participated in elicitation focus groups or interviews (n=48); elicitation interviews with cognitive debriefing (n=23), or cognitive interviews alone (n=12). Mean age of the sample was 65 years (SD=10); 45% were male; mean FEV-1% predicted was 44% (SD=16). Participants characterized exacerbations as a persistent increase in the severity of respiratory symptoms and other systemic manifestations accompanied by a dramatic reduction in activity. Specific attributes included shortness of breath, chest congestion, cough, sputum, chest discomfort, feeling weak or tired, sleep disturbances, and concern or worry. The diary card of 23 candidate items was debriefed in booklet and electronic format.
CONCLUSIONS: Qualitative data from patients and input from experts formed the basis of the EXACT's structure and item pool, ready for empirically based item reduction and reliability and validity testing.
© 2010, International Society for Pharmacoeconomics and Outcomes Research (ISPOR).

Entities:  

Mesh:

Year:  2010        PMID: 20659270     DOI: 10.1111/j.1524-4733.2010.00772.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  48 in total

1.  Chronic obstructive pulmonary disease exacerbations: accurate and easy measurement promises much.

Authors:  Stephen I Rennard; Kristina L Bailey
Journal:  Am J Respir Crit Care Med       Date:  2012-06-01       Impact factor: 21.405

2.  Detecting COPD exacerbations early using daily telemonitoring of symptoms and k-means clustering: a pilot study.

Authors:  Daniel Sanchez-Morillo; Miguel Angel Fernandez-Granero; Antonio León Jiménez
Journal:  Med Biol Eng Comput       Date:  2015-03-01       Impact factor: 2.602

Review 3.  Optimizing bronchodilation in the prevention of COPD exacerbations.

Authors:  Marc Miravitlles; Antonio Anzueto; José R Jardim
Journal:  Respir Res       Date:  2017-06-20

4.  The Short-term Impact of Symptom-defined COPD Exacerbation Recovery on Health Status and Lung Function.

Authors:  Lindsey T Murray; Nancy K Leidy
Journal:  Chronic Obstr Pulm Dis       Date:  2018-01-24

5.  Utility estimation in chronic obstructive pulmonary disease: a preference for change?

Authors:  Jennifer Petrillo; Floortje van Nooten; Paul Jones; Maureen Rutten-van Mölken
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

Review 6.  Early chronic obstructive pulmonary disease: definition, assessment, and prevention.

Authors:  Stephen I Rennard; M Bradley Drummond
Journal:  Lancet       Date:  2015-05-02       Impact factor: 79.321

7.  Use of predictive algorithms in-home monitoring of chronic obstructive pulmonary disease and asthma: A systematic review.

Authors:  Daniel Sanchez-Morillo; Miguel A Fernandez-Granero; Antonio Leon-Jimenez
Journal:  Chron Respir Dis       Date:  2016-04-20       Impact factor: 2.444

8.  Cost-Effectiveness Analysis of a Once-Daily Single-Inhaler Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (COPD) Using the FULFIL Trial: A Spanish Perspective.

Authors:  Melanie Schroeder; Nicole Benjamin; Laura Atienza; Chandroday Biswas; Alan Martin; John D Whalen; José Luis Izquierdo Alonso; Juan Antonio Riesco Miranda; Juan José Soler-Cataluña; Alicia Huerta; Afisi S Ismaila
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-07-10

9.  Measuring respiratory symptoms of COPD: performance of the EXACT- Respiratory Symptoms Tool (E-RS) in three clinical trials.

Authors:  Nancy K Leidy; Lindsey T Murray; Brigitta U Monz; Linda Nelsen; Mitchell Goldman; Paul W Jones; Elizabeth J Dansie; Sanjay Sethi
Journal:  Respir Res       Date:  2014-10-07

10.  Capturing Exacerbations of Chronic Obstructive Pulmonary Disease with EXACT. A Subanalysis of FLAME.

Authors:  Stefan M Frent; Kenneth R Chapman; Michael Larbig; Alexander Mackay; Robert Fogel; Florian S Gutzwiller; Steven Shen; Francesco Patalano; Donald Banerji; Konstantinos Kostikas; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2019-01-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.